相关实验视频
Updated: Jan 14, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.2K
从DCD和DBD捐赠者的儿科脏移植的长期结果:一个比较的OPTN研究
Alicia Paessler1, Joe Brierley1, Marion Siebelink2
1Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
概括
从已故脑死亡 (DBD) 和已故捐赠循环死亡 (DCD) 捐赠者的儿科脏移植显示了类似的长期存活率. 尽管DCD移植的功能延迟率较高,但结果相似,使其成为儿童的可行选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植免疫学 移植免疫学
- 儿科手术 儿科手术
背景情况:
- 已故捐赠者的移植对于儿科末期病至关重要.
- 器官短缺需要探索所有可用的捐赠者类型,包括循环死亡 (DCD) 后的捐赠.
- 在儿科接受者中,DCD与DBD移植的长期结果需要进一步调查.
研究的目的:
- 为了比较使用已故脑死亡 (DBD) 与已故捐赠循环死亡 (DCD) 捐赠者的儿科脏移植的长期结果.
- 评估儿童中DBD和DCD移植之间的移植和患者存活率.
- 评估DCD脏移植作为儿科接受者的选择的可行性.
主要方法:
- 使用美国的器官采购和移植网络 (OPTN) 注册表,对1994-2020年间的儿科移植数据进行了回顾性分析.
- 接受DBD和DCD死者捐赠脏移植的人之间的结果比较.
- 统计分析延迟的异体移植功能,异体移植存活率和10年患者存活率.
主要成果:
- 总共分析了11,071例儿科已故捐赠者移植,其中350例来自DCD捐赠者.
- 与DBD移植相比,DCD移植患者的异位移植功能延迟的发生率较高 (20.1%对11.9%,p < 0.01).
- 在DBD和DCD供体组之间,在10年全移植存活率 (56%对55%,p=0.76) 或患者存活率 (90%对91%,p=0.89) 中没有发现显著差异.
结论:
- 来自DCD捐赠者的儿科移植,尽管最初的功能延迟率较高,但与DBD捐赠者相比,可比的长期全移植和患者存活率.
- 对于需要移植的儿童来说,DCD移植是一种可行的和重要的选择,可以增加器官的可用性.
- 这些发现支持在政策讨论中考虑为儿科接受者进行DCD移植,以扩大移植机会.
相关概念视频
01:28Kidney Transplant I: Introduction
339
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
339
01:26Kidney Transplant II: Surgical Procedure
303
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
303
01:16Kidney Transplant III: Nursing Management
312
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
312
01:22Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
01:25Chronic Kidney Disease I: Introduction
557
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
557